CYCLERION THERAPEUTICS, INC.

Profile

Company Names

CYCLERION THERAPEUTICS, INC.

Addresses

245 FIRST STREET, 18TH FLOOR, CAMBRIDGE, MA 02142

301 BINNEY STREET, CAMBRIDGE, MA 02142

Phone Numbers

(857) 327-8778

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2018

State Incorporated:

MASSACHUSETTS

Total Amount Raised:

$222,278,000.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2023-05-19 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
3
2021-06-07 
$18,028,000.00 
$18,028,000.00 
$0.00 
Equity 
2
2020-07-29 
$24,250,000.00 
$24,250,000.00 
$0.00 
Equity 
1
2019-04-02 
$175,000,000.00 
$175,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANDREAS 
 
BUSCH 
EXECUTIVE OFFICER
CYCLERION THERAPEUTICS, INC.
ANDREAS 
E. 
BUSCH 
EXECUTIVE OFFICER
CYCLERION THERAPEUTICS, INC.
KEVIN 
 
CHURCHWELL 
DIRECTOR
CYCLERION THERAPEUTICS, INC.
GEORGE 
 
CONRADES 
DIRECTOR
CYCLERION THERAPEUTICS, INC.
MARK 
G. 
CURRIE 
EXECUTIVE OFFICER
IRONWOOD PHARMACEUTICALS INC   |  CYCLERION THERAPEUTICS, INC.   |  SEA PHARMACEUTICALS, LLC
ERROL 
 
DE SOUZA 
DIRECTOR
BIONOMICS LIMITED/FI   |  CYCLERION THERAPEUTICS, INC.
MARSHA 
 
FANUCCI 
DIRECTOR
IRONWOOD PHARMACEUTICALS INC   |  SYROS PHARMACEUTICALS, INC.   |  CYCLERION THERAPEUTICS, INC.
CHERYL 
 
GAULT 
EXECUTIVE OFFICER
CYCLERION THERAPEUTICS, INC.
ANJEZA 
 
GJINO 
EXECUTIVE OFFICER
CYCLERION THERAPEUTICS, INC.
PETER 
M. 
HECHT 
EXECUTIVE OFFICER, DIRECTOR
IRONWOOD PHARMACEUTICALS INC   |  CYCLERION THERAPEUTICS, INC.
WILLIAM 
 
HUYETT 
EXECUTIVE OFFICER
CYCLERION THERAPEUTICS, INC.
STEVEN 
 
HYMAN 
DIRECTOR
PRESIDENT + FELLOWS OF HARVARD COLLEGE   |  Q-STATE HOLDINGS, INC.   |  VOYAGER THERAPEUTICS, INC.   |  CYCLERION THERAPEUTICS, INC.
OLE 
 
ISACSON 
DIRECTOR
CYCLERION THERAPEUTICS, INC.
STEPHANIE 
 
LOVELL 
DIRECTOR
CYCLERION THERAPEUTICS, INC.   |  ACCOMPANY HEALTH, INC.
TERRANCE 
 
MCGUIRE 
DIRECTOR
MICROCHIPS, INC.   |  ARSENAL MEDICAL, INC.   |  ADIMAB, INC.   |  ARSANIS, INC.   |  ARSENAL VASCULAR, INC.   |  ARSENAL MEDICAL, INC.   |  ADIMAB, LLC   |  480 BIOMEDICAL, INC.   |  POLARIS ENTREPRENEURS- FUND VII, L.P.   |  PULMATRIX OPERATING COMPANY, INC.   |  PULMATRIX, INC.   |  ICELANDIC PROVISIONS, INC.   |  SEER BIOSCIENCES, INC.   |  CYCLERION THERAPEUTICS, INC.   |  ANKYRA THERAPEUTICS, INC.   |  ADAGIO THERAPEUTICS, INC.   |  FARADAY PHARMACEUTICALS, INC.   |  TECTONIC THERAPEUTIC, INC.
MICHAEL 
 
MENDELSOHN 
DIRECTOR
REGADO BIOSCIENCES INC   |  CARDURION PHARMACEUTICALS, LLC   |  CYCLERION THERAPEUTICS, INC.   |  CARDURION PHARMACEUTICALS, INC.
AMY 
 
SCHULMAN 
DIRECTOR
ARSANIS, INC.   |  SUONO BIO, INC.   |  QUENTIS THERAPEUTICS, INC.   |  GLYMPSE BIO, INC.   |  CYCLERION THERAPEUTICS, INC.   |  CARDURION PHARMACEUTICALS, INC.   |  FRACTYL LABORATORIES INC.   |  AMAGMA, INC.   |  BYHEART, INC.   |  QURALIS CORP   |  FRACTYL HEALTH, INC.   |  LYNDRA THERAPEUTICS, INC.   |  THIRTY MADISON, INC.   |  VOLASTRA THERAPEUTICS, INC.   |  POLARIS PARTNERS X, L.P.   |  SEQUELAE, INC.   |  NOETIK INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-05-25
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2023-05-19 
2021-06-17
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2021-06-07 
2020-08-11
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2020-07-29 
2019-04-17
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2019-04-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
J.P. MORGAN SECURITIES LLC
79
NONE
NONE
CREDIT SUISSE SECURITIES (USA) LLC
816